Does tricuspid regurgitation worsen with age?

Does Tricuspid Regurgitation Worsen with Age?

Yes, tricuspid regurgitation (TR) definitively worsens with age, with the prevalence of secondary TR increasing progressively in older populations and demonstrating marked individual variability in progression rates.

Epidemiologic Evidence of Age-Related Progression

The relationship between TR and aging is well-established across multiple recent studies:

• Prevalence increases substantially with age: In community-dwelling older adults (mean age 81 years), TR prevalence reaches 37% (29% mild, 7% moderate, 1% severe) 1. The TREY Registry of patients ≥60 years old found 58% had at least mild TR (42% mild, 16% moderate/severe) 2.

• Population aging drives rising TR burden: The overall incidence of TR continues to rise, primarily attributable to population aging and improved diagnostic imaging 3. This demographic shift makes TR an increasingly common clinical problem 4.

Progression Patterns and Rates

TR progression shows significant temporal acceleration, particularly in patients starting with moderate disease 5:

• Patients with baseline moderate TR progress at rates of 4.9% at 1 year, 10.1% at 2 years, and 24.8% at 3 years
• Overall, 19% of patients with at least moderate TR experienced progression over a median 2.3-year follow-up
• Marked individual variability exists, making precise prediction challenging

Key Predictors of Progression

Independent risk factors for TR worsening include 5:

• Older age (HR: 1.03 per year)
• Lower body mass index (HR: 0.95)
• Chronic kidney disease (HR: 1.55)
• Worse NYHA functional class (HR: 1.52)
• Right ventricular dilation (HR: 1.33)

Pathophysiologic Mechanisms in Aging

TR progression in elderly patients involves progressive remodeling that begins even with mild disease 2:

• Even mild TR (compared to none/trace) associates with significant tricuspid valve and right heart chamber remodeling
• Three major determinants drive secondary TR development:
  1. Tricuspid annular dilatation (diastolic diameter >40 mm)
  2. Increased leaflet tethering (tenting area expansion)
  3. Leaflet elongation

The presence of all three criteria predicts moderate/severe TR in 72.4% of cases, versus only 5.5% with none of these features 2.

Clinical Consequences of Age-Related TR

The mortality impact becomes significant when TR reaches moderate or greater severity:

• Moderate/severe TR associates with 41.5% all-cause mortality versus 17.4-21.1% for lesser degrees 2
• Greater TR severity independently predicts incident heart failure (HR: 1.28 per severity category increment) even after adjusting for left ventricular function 1
• TR progression itself—regardless of initial severity—determines survival and increases heart failure hospitalizations 5

Structural Deterioration with Progression

As TR worsens with age, patients develop 5:

• Progressive chamber dilation
• Decreased ventriculoarterial coupling
• Reduced left ventricular ejection fraction
• Worsening cardiac structure and function 1

Clinical Implications

The age-related progression of TR mandates earlier identification and intervention before advanced disease develops:

• Female sex and older age are consistently associated with greater TR severity 1
• The historical perception of TR as benign is outdated; it clearly increases morbidity and mortality 3
• Intervention should occur before disease becomes too advanced, ideally at low or intermediate surgical risk scores 4

Common Pitfall to Avoid

Do not dismiss mild TR in elderly patients as inconsequential—it represents the beginning of a progressive remodeling process that accelerates over time and carries significant prognostic implications once moderate severity is reached.

budget:budget_used 6481 193519